BioSpace News Archive

Cold plasma isn’t in thermodynamic balance either because of distinction in particle and electron temperature or if speed dispersion of species does not take after Maxwell Boltzmann circulation.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global gamma probe devices market is projected to exhibit a CAGR of 10% during the forecast period between 2020 to 2030, predicts Fact.MR.

Masimo announced the findings of a prospective study published in Anesthesia & Analgesia in which Dr. Claudia Spies and colleagues investigated the relationship between parameters derived from electroencephalogram spectra, measured using Masimo SedLine® Brain Function Monitoring, and postoperative delirium in older patients undergoing elective surgery.

Anders Ullman, M.D., Ph.D., currently a member of the Board of Directors of Sobi, will become Head of R&D and Chief Medical Officer and replace Ravi Rao, M.D., Ph.D.

Rejuveron Life Sciences AG, a Zürich-based biotechnology company developing technologies for healthy aging, today announced that it has strengthened its support to a near-majority holding in Endogena Therapeutics Inc., an endogenous regenerative therapeutics company.

HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases, and Korean biotech Quratis Inc. announced the first healthy volunteers in South Korea have been dosed in a Phase 1 trial of HDT Bio’s revolutionary COVID-19 RNA vaccine for distribution in South Korea and neighboring countries.

Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced the appointment of Mike Sergesketter as Interim Chief Financial Officer, effective immediately.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced its inaugural issuance of a $1 billion sustainability bond, which was part of an $8 billion underwritten public offering of notes that closed on Dec. 10, 2021.

COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the results from its exploratory study of COMP360 psilocybin therapy in conjunction with SSRI use.

Increase in the prevalence of uterine fibroids in women is anticipated to bolster the growth of the global laparoscopic power morcellators market in coming years.